Luthra And Luthra Advised Orchid Pharma With Its QIP Worth INR 400 Crores
LIVELAW NEWS NETWORK
5 July 2023 4:00 AM GMT
Listen to this Article
The Firm’s Capital Markets team advised Orchid Pharma Limited, a Tamil Nadu based pharmaceutical manufacturing company, in connection with its qualified institutions placement of 9,902,705 equity shares aggregating to ₹400 crore. The lead managers to this QIP were Edelweiss Financial Services Limited and JM Financial Limited.
The transaction team was led by Partner, Geeta Dhania, with due assistance from Senior Associate, Tripti Pandey, and Associates – Sakshi Mandal, Ridhi Jain, Shreeya Srungarapu, Vedaarth Uberoi and Abhishek Gupta.
Next Story
